RNA Delivery Business With Liberate's Shawn Davis, Ph.D., & Walter Strapps, Ph.D.
Earlier this year, Shawn Davis, Ph.D., left a pretty comfortable position at AstraZeneca to lead Liberate Bio. He brought along another industry notable in Walter Strapps, Ph.D., to serve as CSO. Why'd they do it? Because RNA delivery is such a crucial step toward revolutionary genetic medicine, but it's tough science. They think they can change that. Hear their story on the latest episode of the Business of Biotech.
In this article, we outline the AI- and ML-related documents and guidances the FDA and EMA have released thus far, comparing and contrasting their areas of focus and concern.
Cardior Pharmaceuticals, led by CEO and cofounder Claudia Ulbrich, is developing what may be a much broader approach to heart failure, one that seeks to restore the diseased heart to its natural healthy state.
We incorporate organization/project activities, milestones, people resources, financial resources, and many other inputs into our planning tools. So why do so many talented strategic planners not include decision points in their planning tools?
Inside you will find more on:
- Drug Development Strategies
- AI Predictions In Pharma
- Risk Mitigation
- Tips For The Talent Shortage
View the digital edition.
CONTRIBUTE TO LIFE SCIENCE LEADER
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.
|Connect With Life Science Leader:|